|
GILD
|
Gilead Sciences, Inc.
|
8.19%
|
US
|
NASDAQ
|
|
AMGN
|
Amgen Inc.
|
7.85%
|
US
|
NASDAQ
|
|
REGN
|
Regeneron Pharmaceuticals, Inc.
|
7.12%
|
US
|
NASDAQ
|
|
VRTX
|
Vertex Pharmaceuticals Incorporated
|
7.00%
|
US
|
NASDAQ
|
|
MRNA
|
Moderna, Inc.
|
5.62%
|
US
|
NASDAQ
|
|
BIIB
|
Biogen Idec Inc.
|
3.74%
|
US
|
NASDAQ
|
|
IQV
|
IQVIA Holdings, Inc.
|
3.57%
|
US
|
NYSE
|
|
MTD
|
Mettler-Toledo International, Inc.
|
3.00%
|
US
|
NYSE
|
|
ILMN
|
Illumina, Inc.
|
2.98%
|
US
|
NASDAQ
|
|
ALNY
|
Alnylam Pharmaceuticals, Inc.
|
2.59%
|
US
|
NASDAQ
|
|
BNTX
|
BioNTech SE
|
2.54%
|
US
|
NASDAQ
|
|
SGEN
|
Seattle Genetics, Inc.
|
2.35%
|
US
|
NASDAQ
|
|
GMAB
|
Genmab A/S
|
1.97%
|
US
|
NASDAQ
|
|
BMRN
|
BioMarin Pharmaceutical Inc.
|
1.87%
|
US
|
NASDAQ
|
|
WAT
|
Waters Corporation
|
1.80%
|
US
|
NYSE
|
|
INCY
|
Incyte Corporation
|
1.68%
|
US
|
NASDAQ
|
|
BGNE
|
BeiGene, Ltd.
|
1.61%
|
US
|
NASDAQ
|
|
ARGX
|
argenx SE
|
1.44%
|
US
|
NASDAQ
|
|
TECH
|
Techne Corporation
|
1.20%
|
US
|
NASDAQ
|
|
UTHR
|
United Therapeutics Corporation
|
1.16%
|
US
|
NASDAQ
|